Su, Yajuan
Wang, Wentao
Wang, Xingyuan
Xu, Songlin
Li, Anrui
Teng, Lichen
Funding for this research was provided by:
Haiyan Founding project of Harbin Medical University Cancer Hospital (NO. JJMS 2022-14)
Innovation funding for technology of Harbin Medical University Cancer Hospital (NO. 2023-1-S-13)
Article History
Received: 12 February 2025
Accepted: 23 November 2025
First Online: 27 March 2026
Declarations
:
: The authors declare no competing interests.
: For clinical samples, written informed consents were obtained, and the protocol was approved by the Ethical Committee of Harbin Medical University Cancer Hospital (No.KY2023-34). Animal experiments are conducted in accordance with ARRIVE guideline and approved by Experimental Animal Ethics Committee of Yangzhou University (No.202406026).